Education
About Us
Working with TipRanks
Follow Us
Matthew Eckler Profile - RBC Capital Analyst
4 Followers
Matthew Eckler RBC Capital
Wall Street Analyst
Success Rate
5 out of 13 ratings made a profit
Average Return
+25.00%
Average return per rating
Time Frame
Compare to
Copying Matthew Eckler's trades since 2017 and holding each position for 1 Year would result in 38.46% of your transactions generating a profit, with an average return of 25.0% per rating.
Stock Rating Distribution
56.00% Buy
44.00% Hold
0.00% Sell
Distribution of Matthew Eckler's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
Best Rating
The most profitable rating made by Matthew Eckler
Matthew Eckler's Stock Coverage
ImmunoGen
Jul 06, 2017
Buy
Upgraded
―
2Ratings
+50.50%
Abeona Therapeutics
Sep 14, 2017
Buy
Initiated
$23.00
(329.10% Upside)
1Ratings
+2.50%
Dynavax
Sep 25, 2017
Buy
Reiterated
$28.00
(181.12% Upside)
2Ratings
-27.90%
Inovio Pharmaceuticals
Oct 18, 2017
Buy
Initiated
$11.00
(328.02% Upside)
1Ratings
-12.60%
Epizyme
Nov 02, 2017
Hold
Downgraded
―
2Ratings
-7.60%
Puma Biotechnology
Nov 10, 2017
Hold
Reiterated
$108.00
(2009.38% Upside)
5Ratings
―
0.00%
Sarepta Therapeutics
Jan 22, 2018
Buy
Initiated
$80.00
(261.83% Upside)
4Ratings
+145.00%
PTC Therapeutics
Jan 29, 2018
Hold
Initiated
$30.00
(-54.70% Downside)
4Ratings
―
0.00%
Spark Therapeutics
Feb 08, 2018
Buy
Initiated
―
4Ratings
-21.68%
List of latest recommendations made by Matthew Eckler. Click to expand and see Matthew Eckler's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Matthew Eckler activity FAQ
What is the performance of Matthew Eckler's recommendations?
The percentage of profitable recommendations made by Matthew Eckler is 38%, and the average return per transaction is 25.00%.
What was Matthew Eckler's most profitable rating?
Matthew Eckler’s most profitable ratings was a buy on SRPT stock on Jul 20, 2017 - Jul 20, 2018. The return on the trade was +225.70%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here